颈动脉支架置入术前使用他汀类药物:系统评价与荟萃分析
该系统评价与荟萃分析纳入11项研究共4088例患者,评估颈动脉支架置入术前使用他汀与围手术期不良事件的关系。结果显示术前他汀治疗与卒中风险(OR 0.39,95%CI 0.27~0.58,p<0.01;I²=0%)和死亡风险(OR 0.30,95%CI 0.10~0.96,p=0.042;I²=0%)降低显著相关,但与短暂性脑缺血发作或心肌梗死风险降低无关联。
要点
- 术前他汀治疗与颈动脉支架置入术后卒中风险降低显著相关(OR 0.39,95%CI 0.27~0.58)。
- 术前他汀治疗与死亡风险降低显著相关(OR 0.30,95%CI 0.10~0.96,p=0.042)。
- 他汀使用与短暂性脑缺血发作或心肌梗死风险降低无显著关联。
核心结论
- 颈动脉支架置入术前他汀治疗与围手术期卒中和死亡风险降低相关,对短暂性脑缺血发作或心肌梗死发生率无影响。
研究设计与样本
- 随机效应荟萃分析纳入所有报告30天卒中、短暂性脑缺血发作、心肌梗死和死亡结局的英文随机及观察性研究,共11项研究4088例患者。
- 使用I²统计量评估异质性,并进行荟萃回归分析探讨试验水平基线特征对结局事件风险关联的影响。
主要发现
- 术前接受他汀治疗的患者卒中风险显著低于未接受者(OR 0.39,95%CI 0.27~0.58,p<0.01;I²=0%)。
- 术前接受他汀治疗的患者死亡风险显著低于未接受者(OR 0.30,95%CI 0.10~0.96,p=0.042;I²=0%)。
- 他汀使用与短暂性脑缺血发作或心肌梗死风险降低无显著关联。
- 荟萃回归分析中,其他试验水平基线特征对他汀治疗与死亡或卒中的关联无显著影响。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine through meta-analysis whether administration of statins before carotid artery stenting (CAS) is associated with fewer periprocedural adverse events. METHODS: All randomized and observational English-language studies of periprocedural statin administration prior to CAS that reported the outcomes of interest (stroke, transient ischemic attack, myocardial infarction, and death at 30 days) were included in a random-effects meta-analysis. The I2 statistic was used to assess heterogeneity. Meta-regression analysis was performed to determine whether an association of statin treatment with risk of outcome events was influenced by other trial-level baseline characteristics of statin-treated and untreated patients. RESULTS: Eleven studies comprising 4088 patients were included. Patients who received statins prior to CAS had a significantly lower risk of stroke (OR 0.39, 95% CI 0.27 to 0.58, p<0.01; I2=0%) and death (OR 0.30, 95% CI 0.10 to 0.96, p=0.042; I2=0%). Statin use was not associated with a reduced risk of transient ischemic attack or myocardial infarction. In meta-regression analysis, other trial-level baseline characteristics had no significant influence on the association of statin treatment with death or stroke. CONCLUSION: Statin therapy prior to CAS is associated with decreased risk of perioperative stroke and death without any effect on the rates of transient ischemic attack or myocardial infarction.
引用
- Texakalidis P, Giannopoulos S, Jonnalagadda AK, et al. Preoperative Use of Statins in Carotid Artery Stenting: A Systematic Review and Meta-analysis. J Endovasc Ther. 2018. PMID: 30101624. doi:10.1177/1526602818794030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。